|
gptkbp:instanceOf
|
cytokine
glycoprotein hormone
|
|
gptkbp:approvedDrugName
|
gptkb:darbepoetin_alfa
gptkb:epoetin_alfa
|
|
gptkbp:binds
|
erythropoietin receptor
|
|
gptkbp:CASNumber
|
11096-26-7
|
|
gptkbp:category
|
gptkb:drug
hormone
erythropoiesis-stimulating agent
hematopoietic growth factor
|
|
gptkbp:decreasedIn
|
high oxygen levels
|
|
gptkbp:discoveredBy
|
gptkb:Allan_J._Erslev
|
|
gptkbp:encodedBy
|
gptkb:EPO_gene
|
|
gptkbp:firstIsolatedFrom
|
1977
|
|
gptkbp:foundIn
|
blood plasma
|
|
gptkbp:glycosylation
|
present
|
|
gptkbp:halfLife
|
4-13 hours
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Erythropoietin
|
|
gptkbp:improves
|
gptkb:hypoxia
|
|
gptkbp:marketedAs
|
gptkb:Reliance_Life_Sciences
gptkb:Pfizer
gptkb:Dr._Reddy's_Laboratories
gptkb:Johnson_&_Johnson
gptkb:Sanofi
gptkb:Sandoz
gptkb:Zydus_Cadila
gptkb:CinnaGen
gptkb:Intas_Pharmaceuticals
gptkb:Amgen
gptkb:Biocon
gptkb:Novartis
gptkb:Roche
gptkb:Hospira
gptkb:Ranbaxy_Laboratories
gptkb:Cipla
gptkb:LG_Life_Sciences
Teva
|
|
gptkbp:MeSH_ID
|
D004894
|
|
gptkbp:molecularWeight
|
34 kDa
|
|
gptkbp:producedBy
|
gptkb:kidney
liver
|
|
gptkbp:promotion
|
erythropoiesis
|
|
gptkbp:regulates
|
red blood cell production
|
|
gptkbp:sideEffect
|
hypertension
thrombosis
pure red cell aplasia
|
|
gptkbp:structure
|
165 amino acids
|
|
gptkbp:UNII
|
QGJ20R5F0Y
|
|
gptkbp:usedAs
|
performance-enhancing drug
|
|
gptkbp:usedFor
|
treatment of chronic kidney disease
treatment of anemia
treatment of chemotherapy-induced anemia
|
|
gptkbp:bfsParent
|
gptkb:EP
|
|
gptkbp:bfsLayer
|
5
|